Comerica Bank Cuts Holdings in Intuitive Surgical, Inc. $ISRG

Comerica Bank reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 89,160 shares of the medical equipment provider’s stock after selling 3,853 shares during the quarter. Comerica Bank’s holdings in Intuitive Surgical were worth $50,497,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also made changes to their positions in the company. Holos Integrated Wealth LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth $25,000. Newbridge Financial Services Group Inc. raised its position in shares of Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 33 shares during the period. Greykasell Wealth Strategies Inc. purchased a new position in shares of Intuitive Surgical in the 3rd quarter worth $27,000. Olistico Wealth LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at $28,000. Finally, Caitlin John LLC acquired a new stake in Intuitive Surgical in the 3rd quarter valued at $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 beat and accelerating growth — ISRG reported a better-than-expected Q1 (EPS $2.50 vs. $2.08 consensus) with ~23% revenue growth and commentary pointing to rising procedures and an improved outlook, which underpins the stock’s upside today. Intuitive Surgical Beats Q1 — TipRanks
• Positive Sentiment: Innovation and pricing power — Coverage notes revenue is outpacing procedures as the da Vinci 5 platform drives higher ASPs and service/consumable mix, supporting margin and longer-term upside. Innovation-Led Growth — Zacks
• Positive Sentiment: Analyst support — Several sell‑side actions are favorable: Robert W. Baird raised its price target to $610 and BTIG reaffirmed a Buy; Goldman published a bullish outlook, adding conviction to the post‑earnings rally. Baird Raises PT — AmericanBankingNews BTIG Reaffirms Buy — AmericanBankingNews
• Neutral Sentiment: Mixed analyst moves — Some firms trimmed targets (Jefferies to $515, Leerink and others adjusted targets), leaving consensus views varied; this increases volatility around near‑term price action. Jefferies Lowers PT — AmericanBankingNews
• Neutral Sentiment: Short interest signal is uninformative — April data reported no meaningful short interest (0 shares reported), so short-squeeze risk appears minimal based on the published figures.
• Neutral Sentiment: Contained cyber incident disclosed — Management reported a contained cyber event with remediation underway; investors will watch disclosures but the company says operations are not materially disrupted. Cybersecurity and Q1 Coverage — Yahoo
• Negative Sentiment: Instrument recalls raise reliability questions — ISRG initiated multiple recalls of reusable da Vinci instruments after safety complaints (fraying/broken cables); recalls could pressure service/consumables revenue and hospital confidence if issues persist. Recalls and Revenue Risk — Yahoo
• Negative Sentiment: Competition creeping in — Johnson & Johnson earned CE mark for a stapler that integrates with Ottava, signaling incremental competition in the surgical robotics ecosystem that investors should monitor. J&J CE Mark — MedTechDive

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $482.22 on Monday. The business has a 50-day moving average of $477.47 and a 200-day moving average of $516.38. The company has a market capitalization of $170.78 billion, a PE ratio of 58.45, a P/E/G ratio of 3.88 and a beta of 1.68. Intuitive Surgical, Inc. has a 1-year low of $427.84 and a 1-year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. The company had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The company’s revenue was up 23.0% on a year-over-year basis. During the same period last year, the firm earned $1.81 earnings per share. On average, equities analysts expect that Intuitive Surgical, Inc. will post 8.51 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ISRG. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. The Goldman Sachs Group increased their price target on Intuitive Surgical from $609.00 to $621.00 and gave the company a “buy” rating in a report on Wednesday, April 22nd. BTIG Research reiterated a “buy” rating and issued a $574.00 price target on shares of Intuitive Surgical in a report on Wednesday, April 22nd. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 30th. Finally, Leerink Partners lowered their price target on Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a report on Wednesday, April 22nd. Eighteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $581.91.

Insiders Place Their Bets

In other news, SVP Patricia L. Wadors sold 220 shares of the firm’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $499.71, for a total transaction of $109,936.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Fredrik Widman sold 133 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the sale, the vice president owned 660 shares of the company’s stock, valued at $326,673.60. This represents a 16.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 32,943 shares of company stock valued at $17,279,568 over the last ninety days. Insiders own 0.60% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.